Intuitive Surgical, a leader in robotic-assisted surgery, recently unveiled its fourth-quarter financial performance, surpassing market expectations for both revenue and earnings per share. This robust financial showing was primarily fueled by a substantial increase in surgical procedure volumes using its flagship da Vinci systems, alongside a rise in new system installations globally. The positive results underscore the company's continued dominance and growth trajectory in the medical technology sector, leading to an immediate positive response in its stock value.
For the fourth fiscal quarter, Intuitive Surgical recorded an impressive $2.87 billion in revenue, comfortably outperforming the analyst consensus of $2.75 billion. Concurrently, the company reported adjusted earnings of $2.53 per share, also exceeding the anticipated $2.26 per share. This strong financial uplift represents a 19% year-over-year revenue growth, largely attributed to the expanded adoption of its da Vinci surgical systems and the consequent increase in their installed base worldwide.
A key driver of this success was the approximately 18% year-over-year growth in global da Vinci procedures. During the quarter, Intuitive Surgical successfully deployed 532 da Vinci surgical systems, an increase from 493 units in the corresponding period of the previous year. By the close of December 2025, the total installed base of da Vinci systems had reached 11,106, marking a significant 12% expansion from the prior year. Furthermore, the company's financial liquidity remained strong, with cash, cash equivalents, and investments totaling $9.03 billion, reflecting a $600 million increase over the quarter.
Looking ahead, Intuitive Surgical projects continued growth for its da Vinci procedures, anticipating a 13% to 15% increase for the full year 2026, building on the 18% growth observed in 2025. The company also forecasts a gross profit margin between 67% and 68% of revenue for 2026, aligning closely with the 67.6% margin achieved in 2025. These projections highlight the company's confidence in sustained demand and operational efficiency within the robotic surgery market. Company executives are scheduled to provide further details and insights during an upcoming earnings conference call.
Following the announcement of these strong quarterly results, shares of Intuitive Surgical experienced a positive movement in after-hours trading. The stock saw an increase of 3.04%, reaching $541.78. This upward trend reflects investor confidence in the company's financial health, strategic positioning, and future growth prospects within the evolving landscape of medical technology and robotic surgery.